Literature DB >> 8624867

Regional distribution and kinetics of [18F]6-flurodopamine as a measure of cardiac sympathetic activity in humans.

G Coates1, R Chirakal, E L Fallen, G Firnau, E S Garnett, M V Kamath, A Scheffel, C Nahmias.   

Abstract

OBJECTIVES: To determine whether an increase in cardiac sympathetic activity produced by exercise or sublingual glyceryl trinitrate causes an increased rate of loss of fluorine-18 from the myocardium after intravenous [18F]6-fluorodopamine ([18F]F-DA) in normal volunteers. In addition, to determine the contribution of non-specific uptake of [18F]F-DA in the myocardium in patients with recent heart transplant. PROTOCOL: [18F]F was prepared by direct electrophilic fluorination of dopamine. Nine healthy volunteers each received 1.85 x 10(8) Bq (168-250 micrograms) [18F]F-DA over a period of 3 min and were scanned for 2 h in an ECAT 953/31 tomograph. Three controls were scanned before and after vigorous cycle exercise and two were scanned before and after sublingual glyceryl trinitrate. In addition, two patients (1 and 2 years post-heart transplant) underwent a myocardial perfusion study with ammonia labelled with nitrogen-13 followed by an [18F]F-DA study.
RESULTS: There was intense uniform uptake of [18F]F-DA throughout the myocardium in the healthy volunteers. The time course of 18F in the myocardium under resting conditions fitted a biexponential function with mean half-times of 8.0 and 109 min. Vigorous exercise produced a three to fivefold increase in the rate of loss of 18F compared with that when resting. After glyceryl trinitrate, one control had a profound reduction in blood pressure (23%) and twofold increase in the rate of loss of myocardial 18F. The other control had no physiologically significant change in blood pressure, heart rate, or rate of loss of myocardial 18F. Uptake of [18F]F-DA in the two posttransplant patients was confined to a small anterobasal region adjacent to the atrioventricular groove, while blood flow, as measured with [13N] ammonia, was uniformly distributed throughout the myocardium. Partial reinnervation of the myocardium was confirmed by the presence of distinct low frequency spectral peaks of the heart rate power spectrum in both patients.
CONCLUSIONS: These results suggest that the uptake of [18F]F-DA reflects the distribution of cardiac sympathetic innervation and that the rate of loss of 18F from the myocardium partially reflects spill over of noradrenaline. The technique may be useful in investigating various cardiac conditions in which the sympathetic system is compromised.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624867      PMCID: PMC484217          DOI: 10.1136/hrt.75.1.29

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  27 in total

1.  Effects of steady state exercise on the power spectrum of heart rate variability.

Authors:  M V Kamath; E L Fallen; R McKelvie
Journal:  Med Sci Sports Exerc       Date:  1991-04       Impact factor: 5.411

2.  Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method.

Authors:  J Delforge; A Syrota; J P Lançon; K Nakajima; C Loc'h; M Janier; J M Vallois; J Cayla; C Crouzel
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

3.  Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.

Authors:  P C Chang; K Szemeredi; E Grossman; I J Kopin; D S Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

4.  Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts--implications for clinical studies.

Authors:  M W Dae; T De Marco; E H Botvinick; J W O'Connell; R S Hattner; J P Huberty; M S Yuen-Green
Journal:  J Nucl Med       Date:  1992-08       Impact factor: 10.057

5.  Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy.

Authors:  K Nakajima; H Bunko; J Taki; M Shimizu; A Muramori; K Hisada
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

6.  Positron emission tomographic imaging of cardiac sympathetic innervation and function.

Authors:  D S Goldstein; P C Chang; G Eisenhofer; R Miletich; R Finn; J Bacher; K L Kirk; S Bacharach; I J Kopin
Journal:  Circulation       Date:  1990-05       Impact factor: 29.690

7.  Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamine.

Authors:  D S Goldstein; P C Chang; C B Smith; P Herscovitch; S M Austin; G Eisenhofer; I J Kopin
Journal:  J Nucl Med       Date:  1991-01       Impact factor: 10.057

8.  Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine.

Authors:  S Wakasugi; A Wada; Y Hasegawa; S Nakano; N Shibata
Journal:  J Nucl Med       Date:  1992-02       Impact factor: 10.057

9.  Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias.

Authors:  I T Meredith; A Broughton; G L Jennings; M D Esler
Journal:  N Engl J Med       Date:  1991-08-29       Impact factor: 91.245

10.  Heart rate and plasma catecholamines during 24 h of everyday life in trained and untrained men.

Authors:  F Dela; K J Mikines; M Von Linstow; H Galbo
Journal:  J Appl Physiol (1985)       Date:  1992-12
View more
  3 in total

1.  Natural history and outcome of aortic stenosis diagnosed prenatally.

Authors:  J M Simpson; G K Sharland
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

2.  Efficient automated syntheses of high specific activity 6-[18F]fluorodopamine using a diaryliodonium salt precursor.

Authors:  Kiel D Neumann; Linlin Qin; Amy L Vāvere; Bin Shen; Zheng Miao; Frederick T Chin; Barry L Shulkin; Scott E Snyder; Stephen G DiMagno
Journal:  J Labelled Comp Radiopharm       Date:  2015-12-23       Impact factor: 1.921

Review 3.  Roles of cardiac sympathetic neuroimaging in autonomic medicine.

Authors:  David S Goldstein; William P Cheshire
Journal:  Clin Auton Res       Date:  2018-07-30       Impact factor: 4.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.